The incretin concept was later developed further by identifying the gut hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) as main incretin hormones (6, 7) and the development of GLP-1 as a potential treatment of type 2 diabetes (8). This evidence concerns the gene GLP1R and type 2 diabetes mellitus.